SE454325B - Excipient for en farmakologisk komposition omfattande en inert substans belagd med akrylat- eller metakrylatpolymer eller -sampolymer - Google Patents

Excipient for en farmakologisk komposition omfattande en inert substans belagd med akrylat- eller metakrylatpolymer eller -sampolymer

Info

Publication number
SE454325B
SE454325B SE8204581A SE8204581A SE454325B SE 454325 B SE454325 B SE 454325B SE 8204581 A SE8204581 A SE 8204581A SE 8204581 A SE8204581 A SE 8204581A SE 454325 B SE454325 B SE 454325B
Authority
SE
Sweden
Prior art keywords
excipient
active ingredient
pharmaceutical composition
tablets
composition according
Prior art date
Application number
SE8204581A
Other languages
English (en)
Swedish (sv)
Other versions
SE8204581D0 (sv
SE8204581L (sv
Inventor
L Moro
G Maffione
G Neri
A Rigamonti
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of SE8204581D0 publication Critical patent/SE8204581D0/xx
Publication of SE8204581L publication Critical patent/SE8204581L/
Publication of SE454325B publication Critical patent/SE454325B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
SE8204581A 1981-08-05 1982-08-04 Excipient for en farmakologisk komposition omfattande en inert substans belagd med akrylat- eller metakrylatpolymer eller -sampolymer SE454325B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23374/81A IT1168014B (it) 1981-08-05 1981-08-05 Forme farmaceutiche a cessione protratta

Publications (3)

Publication Number Publication Date
SE8204581D0 SE8204581D0 (sv) 1982-08-04
SE8204581L SE8204581L (sv) 1983-02-06
SE454325B true SE454325B (sv) 1988-04-25

Family

ID=11206523

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204581A SE454325B (sv) 1981-08-05 1982-08-04 Excipient for en farmakologisk komposition omfattande en inert substans belagd med akrylat- eller metakrylatpolymer eller -sampolymer

Country Status (18)

Country Link
US (1) US4499066A (es)
JP (1) JPS5829717A (es)
AT (1) AT381639B (es)
AU (1) AU557693B2 (es)
BE (1) BE894028A (es)
CA (1) CA1217721A (es)
CH (1) CH657046A5 (es)
DE (1) DE3228999C2 (es)
DK (1) DK161182C (es)
FI (1) FI822683L (es)
FR (1) FR2510888B1 (es)
GB (1) GB2107214B (es)
IE (1) IE53614B1 (es)
IL (1) IL66435A0 (es)
IT (1) IT1168014B (es)
NL (1) NL8203057A (es)
SE (1) SE454325B (es)
ZA (1) ZA825553B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2141023B (en) * 1983-06-06 1986-09-03 Robins Co Inc A H Delayed release formulations
IE56459B1 (en) * 1983-12-21 1991-08-14 Elan Corp Ltd Controlled absorption pharmaceutical formulation
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
EP0147780A3 (en) * 1984-01-03 1987-03-11 Merck & Co. Inc. Drug delivery device
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
JPS61236723A (ja) * 1985-04-12 1986-10-22 Fujimoto Seiyaku Kk 持続性ニフエジピン坐剤
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4990335A (en) * 1987-03-25 1991-02-05 E. I. Du Pont De Nemours And Company Use of vinyl alcohol homopolymer and copolymers for tableting active materials
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
NZ224252A (en) * 1987-04-21 1991-09-25 Erba Carlo Spa An anthracycline glycoside and its preparation
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
WO2001080826A2 (en) 2000-04-20 2001-11-01 Bristol-Myers Squibb Company Taste masking coating composition
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
GB0507695D0 (en) * 2005-04-15 2005-05-25 Novartis Ag Organic compounds
JP2008545841A (ja) 2005-06-02 2008-12-18 ノボザイムス アクティーゼルスカブ 不活性粒子及び活性粒子のブレンド
US20060287212A1 (en) * 2005-06-02 2006-12-21 Novozymes A/S Blends of inactive particles and active particles

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US27107A (en) * 1860-02-14 Improvement in cotten-seed planters
US2996431A (en) * 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
NL109293C (es) * 1955-12-22
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
USRE27107E (en) 1968-05-01 1971-03-30 Drug composition
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
US3908003A (en) * 1971-07-02 1975-09-23 American Home Prod Enrobed solid hydrophobic tableting lubricants and compositions
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments

Also Published As

Publication number Publication date
ATA295082A (de) 1986-04-15
US4499066A (en) 1985-02-12
CH657046A5 (de) 1986-08-15
DK345682A (da) 1983-02-06
DK161182B (da) 1991-06-10
DK161182C (da) 1991-11-25
BE894028A (fr) 1983-02-04
CA1217721A (en) 1987-02-10
DE3228999A1 (de) 1983-02-24
AU8660682A (en) 1983-02-10
NL8203057A (nl) 1983-03-01
DE3228999C2 (de) 1991-06-27
GB2107214B (en) 1985-04-24
FI822683L (fi) 1983-02-06
FR2510888A1 (fr) 1983-02-11
AU557693B2 (en) 1987-01-08
GB2107214A (en) 1983-04-27
FR2510888B1 (fr) 1986-03-21
IT8123374A0 (it) 1981-08-05
IE53614B1 (en) 1988-12-21
ZA825553B (en) 1983-06-29
FI822683A0 (fi) 1982-08-02
JPS5829717A (ja) 1983-02-22
IL66435A0 (en) 1982-12-31
AT381639B (de) 1986-11-10
JPH0116808B2 (es) 1989-03-27
IE821861L (en) 1983-02-05
IT1168014B (it) 1987-05-20
SE8204581D0 (sv) 1982-08-04
SE8204581L (sv) 1983-02-06

Similar Documents

Publication Publication Date Title
SE454325B (sv) Excipient for en farmakologisk komposition omfattande en inert substans belagd med akrylat- eller metakrylatpolymer eller -sampolymer
CA2462637C (en) Timed, sustained release multi-particulate dosage forms of propranolol
Hu et al. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets
US5885616A (en) Sustained release drug delivery system suitable for oral administration
EP0305918B1 (en) Controlled release delivery coating formulation for bioactive substances
US5549913A (en) Multilayer matrix systems for the controlled release of active principles
US6960357B2 (en) Chemical delivery device
Schultz et al. A new multiparticulate delayed release system.: Part I: Dissolution properties and release mechanism
DE68907762T2 (de) Arzneizubereitung mit gesteuerter Wirkstofffreisetzung und Verfahren zu deren Herstellung.
EP0280571B1 (en) Sustained release matrix formulations
JPS6230709A (ja) 持続性製剤
EP0542364A1 (en) Controlled release device
WO2004096185A1 (de) Arzneiform und verfahren zu ihrer herstellung
CN103210084A (zh) 黄嘌呤氧化还原酶抑制剂或黄嘌呤氧化酶抑制剂的新的改进的释放剂型
Banerjee et al. Controlled porosity solubility modulated osmotic pump tablets of Gliclazide
EP1372614A1 (en) Controlled release sulfonylurea formulation
CH659584A5 (de) Wirkstoffspender mit aus einem semipermeablen bestandteil und einem magensaftresistenten bestandteil gebildeter wand.
Jalsenjak In vitro release from microcapsules and microspheres
Yu et al. THEOPHYLLINE CONTROLLED‐RELEASE FORMULATIONS: IN VIVO‐‐IN VITRO CORRELATIONS
Zimmerman Use of Metzler's NONLIN program for fitting discontinuous absorption profiles
JP4563642B2 (ja) 医薬製剤
JPH06296856A (ja) マイクロカプセルの皮膜材料
Uhumwangho et al. A Comparative Study Of The Dissolution Characteristics Of Capsule And Tablet Dosage Forms Of Melt Granulations Of Paracetamol N Diluent Effects
KR20210147955A (ko) 삼투압에 의해 방출 조절되는 서방성 메트포르민 코팅 정제 및 이의 제조방법
Mahalpure et al. A review on-controlled-porosity osmotic pump tablet

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8204581-6

Effective date: 19940310

Format of ref document f/p: F